精神分裂症的攻击行为的精神药理学。
Psychopharmacology of aggression in schizophrenia.
机构信息
Department of Psychiatry and Health Behavior, Medical College of Georgia, Georgia Health Sciences University, Augusta, GA 30912, USA.
出版信息
Schizophr Bull. 2011 Sep;37(5):930-6. doi: 10.1093/schbul/sbr104.
Abstract
The management of aggression in patients with schizophrenia is a complex and challenging clinical dilemma. It also is greatly influenced by prevailing societal and medicolegal considerations regarding the perceived associations between violence and mental illness. This article provides a succinct account of a complex area and offers evidence for available treatments to reduce the occurrence of violent behavior among patients with schizophrenia.
摘要
精神分裂症患者的攻击行为管理是一个复杂且具有挑战性的临床难题。它也受到社会和医学法律方面普遍存在的观念的极大影响，这些观念涉及暴力行为和精神疾病之间的关联。本文简要介绍了这一复杂领域，并提供了现有治疗方法的证据，以减少精神分裂症患者发生暴力行为的可能性。
相似文献
1
Psychopharmacology of aggression in schizophrenia.精神分裂症的攻击行为的精神药理学。
Schizophr Bull. 2011 Sep;37(5):930-6. doi: 10.1093/schbul/sbr104.
2
Violence and schizophrenia: clozapine as a specific antiaggressive agent.暴力与精神分裂症：氯氮平作为一种特定的抗攻击药物
Bull Am Acad Psychiatry Law. 1995;23(4):607-11.
3
Antipsychotic treatment of schizophrenics at risk for violence.对有暴力风险的精神分裂症患者进行抗精神病药物治疗。
Pharmacopsychiatry. 2001 Jan;34(1):43-4. doi: 10.1055/s-2001-15192.
4
The psychopharmacology of violence with emphasis on schizophrenia, part 1: acute treatment.暴力行为的精神药理学，重点关注精神分裂症，第1部分：急性治疗
J Clin Psychiatry. 2007 Jan;68(1):163-4. doi: 10.4088/jcp.v68n0121.
5
Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients.长效注射用抗精神病药物用于预防和管理精神病患者的暴力行为。
Int J Clin Pract. 2017 Sep;71(9). doi: 10.1111/ijcp.12997. Epub 2017 Sep 4.
6
A systematic review of the evidence of clozapine's anti-aggressive effects.一项关于氯氮平抗攻击作用的证据的系统评价。
Int J Neuropsychopharmacol. 2012 Oct;15(9):1351-71. doi: 10.1017/S146114571100201X. Epub 2012 Feb 20.
7
Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.非典型抗精神病药物、神经认知缺陷与精神分裂症患者的攻击性
J Clin Psychopharmacol. 2008 Oct;28(5):485-93. doi: 10.1097/JCP.0b013e3181855cd6.
8
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.非典型抗精神病药物治疗精神分裂症和分裂情感性障碍的暴力患者。
Arch Gen Psychiatry. 2006 Jun;63(6):622-9. doi: 10.1001/archpsyc.63.6.622.
9
Heterogeneity of violence in schizophrenia and implications for long-term treatment.精神分裂症中暴力行为的异质性及其对长期治疗的影响。
Int J Clin Pract. 2008 Aug;62(8):1237-45. doi: 10.1111/j.1742-1241.2008.01797.x. Epub 2008 Jun 28.
10
Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.氯氮平联合氨磺必利治疗：英国一家高度戒备医院中难治性暴力型精神分裂症患者的有效治疗策略
CNS Spectr. 2014 Oct;19(5):403-10. doi: 10.1017/S1092852913000874. Epub 2013 Nov 28.
引用本文的文献
1
Violence victimization and perpetration within the caregiver-patient relationship in schizophrenia: A cross-sectional study in Tunisia.精神分裂症患者护理者与患者关系中的暴力受害与施暴情况：突尼斯的一项横断面研究。
PLoS One. 2025 May 30;20(5):e0323312. doi: 10.1371/journal.pone.0323312. eCollection 2025.
2
Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.计算机化认知和社会认知训练在精神分裂症冲动攻击中的应用。
Schizophr Res. 2023 Jun;256:117-125. doi: 10.1016/j.schres.2022.11.004. Epub 2022 Nov 21.
3
Clinical outcomes of paliperidone long-acting injection in patients with schizophrenia: a 1-year retrospective cohort study.长效帕利哌酮注射治疗精神分裂症患者的临床结局：一项为期 1 年的回顾性队列研究。
BMC Psychiatry. 2021 Oct 15;21(1):507. doi: 10.1186/s12888-021-03513-7.
4
Caregivers' Experiences of Aggressive Persons with Schizophrenia.照顾者对精神分裂症攻击性行为患者的体验。
Indian J Psychol Med. 2021 Jan;43(1):10-15. doi: 10.1177/0253717620928728. Epub 2020 Aug 4.
5
Biological Aspects of Aggression and Violence in Schizophrenia.精神分裂症中攻击与暴力行为的生物学方面
Clin Psychopharmacol Neurosci. 2019 Nov 20;17(4):475-486. doi: 10.9758/cpn.2019.17.4.475.
6
A Research Agenda for the Assessment and Management of Acute Behavioral Changes in Elderly Emergency Department Patients.老年人急诊患者急性行为变化评估和管理的研究议程
West J Emerg Med. 2019 Mar;20(2):393-402. doi: 10.5811/westjem.2019.1.39262. Epub 2019 Feb 19.
7
Guidelines for the Pharmacotherapy of Schizophrenia in Adults.成人精神分裂症的药物治疗指南。
Can J Psychiatry. 2017 Sep;62(9):604-616. doi: 10.1177/0706743717720448. Epub 2017 Jul 13.
8
Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies.精神病患者暴力行为的风险因素：110 项研究的系统回顾和荟萃回归分析。
PLoS One. 2013;8(2):e55942. doi: 10.1371/journal.pone.0055942. Epub 2013 Feb 13.
9
Aggression in schizophrenia.精神分裂症中的攻击行为。
Schizophr Bull. 2011 Sep;37(5):897-8. doi: 10.1093/schbul/sbr090.
10
Violence and schizophrenia.暴力与精神分裂症。
Schizophr Bull. 2011 Sep;37(5):877-8. doi: 10.1093/schbul/sbr094.
本文引用的文献
1
Pathways to aggression in schizophrenia affect results of treatment.精神分裂症中的攻击途径会影响治疗效果。
Schizophr Bull. 2011 Sep;37(5):921-9. doi: 10.1093/schbul/sbr041. Epub 2011 May 11.
2
Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.尼古丁替代疗法对精神分裂症吸烟患者激越的影响：一项双盲、随机、安慰剂对照研究。
Am J Psychiatry. 2011 Apr;168(4):395-9. doi: 10.1176/appi.ajp.2010.10040569. Epub 2011 Jan 18.
3
Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.雾化抗精神病药缓解激越：吸入洛沙平治疗与精神分裂症或双相情感障碍相关的激越。
Int J Clin Pract. 2011 Mar;65(3):330-40. doi: 10.1111/j.1742-1241.2010.02615.x. Epub 2010 Dec 29.
4
Informed consent to research in persons with schizophrenia spectrum disorders.精神分裂谱系障碍患者的研究知情同意。
Nurs Ethics. 2010 Jul;17(4):425-34. doi: 10.1177/0969733010364581.
5
Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients.急诊科患者肌肉注射奥氮平与苯二氮䓬类药物联合使用的潜在并发症。
J Emerg Med. 2012 Nov;43(5):889-96. doi: 10.1016/j.jemermed.2010.04.012. Epub 2010 Jun 12.
6
Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.比较肌内注射奥氮平、口腔崩解片奥氮平、口服利培酮溶液和氟哌啶醇肌内注射在台湾急性精神科病房急性激越管理中的效果。
J Clin Psychopharmacol. 2010 Jun;30(3):230-4. doi: 10.1097/JCP.0b013e3181db8715.
7
Regaining mental capacity for treatment decisions following psychiatric admission: a clinico-ethical study.精神科住院后恢复治疗决策能力：临床伦理研究。
Psychol Med. 2011 Jan;41(1):119-28. doi: 10.1017/S0033291710000383. Epub 2010 Mar 29.
8
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.奥氮平肌肉注射治疗激越患者的上市后不良事件病例报告。
J Clin Psychiatry. 2010 Apr;71(4):433-41. doi: 10.4088/JCP.08m04411gry. Epub 2010 Feb 9.
9
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.2009 年精神分裂症 PORT 精神药理学治疗建议和总结陈述。
Schizophr Bull. 2010 Jan;36(1):71-93. doi: 10.1093/schbul/sbp116. Epub 2009 Dec 2.
10
Assessing risk of future violence among forensic psychiatric inpatients with the Classification of Violence Risk (COVR).用《暴力风险分类法》（COVR）评估法医精神病住院患者未来暴力风险。
Psychiatr Serv. 2009 Nov;60(11):1522-6. doi: 10.1176/ps.2009.60.11.1522.
Zotero 插件